TESC and cholangiocarcinoma: Tescalcin (TESC) regulates cytoplasmic pH via interacting with the NA+/H+ exchanger and promotes the progression of colorectal cancer (CRC) by activating the AKT/NF-κB pathway [30]; upregulation of TESC is also involved in the pathogenesis of CC.